XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis

XRCC3 (X-ray repair complementing defective repair in Chinese hamster cells 3) is a member of the RecA/Rad51-related protein family that participates in homologous recombination, maintaining chromosome stability and participating in DNA repair. Attention has been drawn upon the association of XRCC3 Thr241Met polymorphism with breast cancer risk. The present meta-analysis aims to examine whether XRCC3 Thr241Met polymorphism status is associated with breast cancer risk. Apart from the overall meta-analysis, separate analyses were performed on Chinese and non-Chinese populations, in order to investigate race-specific effects. Eligible articles were identified by a search of MEDLINE bibliographical database for the period up to August 2009. Twenty case–control studies on non-Chinese subjects (19,575 cases and 21,125 controls) and three case–control studies on Chinese subjects (1,216 cases and 1,112 controls) were eligible. Pooled odds ratios (OR) were appropriately derived from fixed-effects or random-effects models. At the overall analysis, the T allele was associated with elevated breast cancer risk mainly following a recessive model (pooled OR = 1.064, 95% CI: 1.007–1.124, fixed effects), given that the effect was more pronounced in homozygous carriers (pooled OR = 1.073, 95% CI: 1.010–1.140, fixed effects). The association seemed confined in non-Chinese populations, once again following a recessive model (pooled OR = 1.072, 95% CI: 1.014–1.133, fixed effects). Concerning Chinese populations, no consistent results were demonstrated. In conclusion, the XRCC3 Thr241Met T allele seems associated with elevated breast cancer risk in non-Chinese subjects. The need for additional studies on Chinese populations seems warranted.

[1]  R. Lafrenie,et al.  Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Hunter,et al.  Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  Shizhong Han,et al.  DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case–control studies , 2006, European Journal of Human Genetics.

[4]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[5]  John L Hopper,et al.  Double-Strand Break Repair Gene Polymorphisms and Risk of Breast or Ovarian Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[6]  Daehee Kang,et al.  Genetic polymorphisms and cancer susceptibility of breast cancer in Korean women. , 2003, Journal of biochemistry and molecular biology.

[7]  D. Hunter,et al.  Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study. , 2003, Carcinogenesis.

[8]  Paul D P Pharoah,et al.  Variants in DNA double-strand break repair genes and breast cancer susceptibility. , 2002, Human molecular genetics.

[9]  P. Brennan,et al.  The XRCC3 Thr241Met polymorphism and breast cancer risk: a case–control study in a Thai population , 2007, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[10]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[11]  F. Schmitt,et al.  DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population , 2007, Breast Cancer Research and Treatment.

[12]  Zhenzhong Zhang,et al.  Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[13]  R. Freimanis,et al.  Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. , 2008, Carcinogenesis.

[14]  K. Lohman,et al.  DNA-repair genetic polymorphisms and breast cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  J. Yarnold,et al.  TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  D. Hunter,et al.  Genetic Variations in XRCC2 and XRCC3 Are Not Associated with Endometrial Cancer Risk , 2004, Cancer Epidemiology Biomarkers & Prevention.

[17]  P. Vineis,et al.  Human Genome Epidemiology (huge) Review Xrcc3 and Xpd/ercc2 Single Nucleotide Polymorphisms and the Risk of Cancer: a Huge Review , 2022 .

[18]  J. Błasiak,et al.  Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. , 2008, Mutation research.

[19]  Paul D.P. Pharoah,et al.  Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. , 2007, Journal of the National Cancer Institute.

[20]  W. Au,et al.  Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. , 2003, Environmental health perspectives.

[21]  K. Kyriacou,et al.  Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus , 2008, Breast Cancer Research and Treatment.

[22]  Genica,et al.  Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium , 2006 .

[23]  A. Folsom,et al.  No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study. , 2006, Cancer detection and prevention.

[24]  F. Schmitt,et al.  DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. , 2005, Genetics and molecular research : GMR.

[25]  Nicklas Raun Jacobsen,et al.  No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  Jennifer D. Brooks,et al.  Polymorphisms in RAD51, XRCC2, and XRCC3 Are Not Related to Breast Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[27]  R. Millikan,et al.  Polymorphisms in DNA Repair Genes, Medical Exposure to Ionizing Radiation, and Breast Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[28]  K. Lohman,et al.  Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. , 2003, Cancer letters.

[29]  D. J. Chen,et al.  XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. , 2000, Mutation research.

[30]  S. Chanock,et al.  Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses , 2006, Human Genetics.

[31]  Ji-Yeob Choi,et al.  Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies , 2007, Breast Cancer Research and Treatment.

[32]  Jeremy M. Stark,et al.  Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks , 2002, Oncogene.

[33]  C. Ulrich,et al.  Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[34]  K. Hemminki,et al.  Single nucleotide polymorphisms in breast cancer. , 2004, Oncology reports.

[35]  I. Andrulis,et al.  Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  W. Willett,et al.  Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk , 2009, Breast Cancer Research and Treatment.

[37]  J. Błasiak,et al.  Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer. , 2009, Experimental and molecular pathology.